Kindler HL - Search Results

1

A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumors.

Helft PR, Schilsky RL, Hoke FJ, Williams D, Kindler HL, Sprague E, DeWitte M, Martino HK, Erickson J, Pandite L, Russo M, Lambert JM, Howard M, Ratain MJ. Helft PR, et al. Among authors: kindler hl. Clin Cancer Res. 2004 Jul 1;10(13):4363-8. doi: 10.1158/1078-0432.CCR-04-0088. Clin Cancer Res. 2004. PMID: 15240523 Clinical Trial.

2

Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.

Kindler HL, Belani CP, Herndon JE 2nd, Vogelzang NJ, Suzuki Y, Green MR. Kindler HL, et al. Cancer. 1999 Nov 15;86(10):1985-91. Cancer. 1999. PMID: 10570422 Clinical Trial.

3

Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase.

Schilsky RL, Kindler HL. Schilsky RL, et al. Among authors: kindler hl. Expert Opin Investig Drugs. 2000 Jul;9(7):1635-49. doi: 10.1517/13543784.9.7.1635. Expert Opin Investig Drugs. 2000. PMID: 11060767 Review.

4

Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.

Schilsky RL, Bertucci D, Vogelzang NJ, Kindler HL, Ratain MJ. Schilsky RL, et al. Among authors: kindler hl. J Clin Oncol. 2002 Jan 15;20(2):582-7. doi: 10.1200/JCO.2002.20.2.582. J Clin Oncol. 2002. PMID: 11786589 Clinical Trial.

5

Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.

Mani S, Rudin CM, Kunkel K, Holmlund JT, Geary RS, Kindler HL, Dorr FA, Ratain MJ. Mani S, et al. Among authors: kindler hl. Clin Cancer Res. 2002 Apr;8(4):1042-8. Clin Cancer Res. 2002. PMID: 11948111 Clinical Trial.

6

Oral fluoropyrimidine treatment of colorectal cancer.

Eng C, Kindler HL, Schilsky RL. Eng C, et al. Among authors: kindler hl. Clin Colorectal Cancer. 2001 Aug;1(2):95-103. doi: 10.3816/CCC.2001.n.009. Clin Colorectal Cancer. 2001. PMID: 12445367 Review.

7

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.

Akerley W, Herndon JE, Egorin MJ, Lyss AP, Kindler HL, Savarese DM, Sherman CA, Rosen DM, Hollis D, Ratain MJ, Green MR. Akerley W, et al. Among authors: kindler hl. Cancer. 2003 May 15;97(10):2480-6. doi: 10.1002/cncr.11375. Cancer. 2003. PMID: 12733147 Free article. Clinical Trial.

8

Phase II study of flavopiridol in patients with advanced colorectal cancer.

Aklilu M, Kindler HL, Donehower RC, Mani S, Vokes EE. Aklilu M, et al. Among authors: kindler hl. Ann Oncol. 2003 Aug;14(8):1270-3. doi: 10.1093/annonc/mdg343. Ann Oncol. 2003. PMID: 12881391 Free article. Clinical Trial.

9

Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies.

Ryan CW, Vogelzang NJ, Vokes EE, Kindler HL, Undevia SD, Humerickhouse R, André AK, Wang Q, Carr RA, Ratain MJ. Ryan CW, et al. Among authors: kindler hl. Clin Cancer Res. 2004 Jul 1;10(13):4406-11. doi: 10.1158/1078-0432.CCR-04-0083. Clin Cancer Res. 2004. PMID: 15240529 Clinical Trial.

10

Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors.

Shah MH, Young D, Kindler HL, Webb I, Kleiber B, Wright J, Grever M. Shah MH, et al. Among authors: kindler hl. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6111-8. doi: 10.1158/1078-0432.CCR-04-0422. Clin Cancer Res. 2004. PMID: 15447997 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters